These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 12869297
1. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling? Neuner JM, McCarthy EP, Davis RB, Phillips RS. J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297 [Abstract] [Full Text] [Related]
6. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause]. Perrone G, Capri O, Borrello M, Galoppi P. Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786 [Abstract] [Full Text] [Related]
9. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C. Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905 [Abstract] [Full Text] [Related]
10. Use of hormone replacement therapy in Washington State: is prevention being put into practice? Saver BG, Taylor TR, Woods NF. J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613 [Abstract] [Full Text] [Related]
12. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel. Vinker S, Kaplan B, Yaphe J, Cohen O, Shumla V, Shapira G, Shofty I, Kitai E. Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667 [Abstract] [Full Text] [Related]
13. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal. Lucas R, Barros H. Maturitas; 2007 Jul 20; 57(3):226-32. PubMed ID: 17293067 [Abstract] [Full Text] [Related]
14. Physician recommendation for papanicolaou testing among U.S. women, 2000. Coughlin SS, Breslau ES, Thompson T, Benard VB. Cancer Epidemiol Biomarkers Prev; 2005 May 20; 14(5):1143-8. PubMed ID: 15894664 [Abstract] [Full Text] [Related]
16. Postmenopausal osteoporosis and hormone replacement therapy. Gambacciani M, Vacca F. Minerva Med; 2004 Dec 20; 95(6):507-20. PubMed ID: 15785435 [Abstract] [Full Text] [Related]
17. Understanding attitudes of older women toward hormone replacement therapy. Phelan EA, Buist DS, Anderson LA, Newton KM, Delaney KM, LaCroix AZ. Prev Med; 2001 Jan 20; 32(1):49-56. PubMed ID: 11162326 [Abstract] [Full Text] [Related]
18. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD, Women's Health in Lund Area (WHILA) Study. Menopause; 2000 Jan 20; 7(4):273-81. PubMed ID: 10914621 [Abstract] [Full Text] [Related]
19. Correlates of osteoporosis among Jewish and Arab women aged 45-74 in Israel: national women's health interview survey. Nitzan-Kaluski D, Chinich A, Ifrah A, Merom D, Green MS. J Gend Specif Med; 2003 Jan 20; 6(1):17-23. PubMed ID: 12661173 [Abstract] [Full Text] [Related]